Autori: El-Galaly Tarec Christoffer
| Naslov | Validation of US Consensus Eligibility Criteria for Front-Line DLBCL Trials (Article; Early Access) |
| Autori | Jelicic Jelena J Juul-jensen Karen Bukumiric Zoran M Rask Kragh Jorgensen Rasmus Runason Simonsen Mikkel Roost Clausen Michael Ludvigsen Al-mashhadi Ahmed Schou Pedersen Robert Poulsen Christian Bjorn Gang Anne Ortved Brown Peter El-galaly Tarec Christoffer Stauffer Larsen Thomas |
| Info | EUROPEAN JOURNAL OF HAEMATOLOGY, (2025), vol. br. , str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: |
| Naslov | Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models (Article) |
| Autori | Jelicic Jelena J Juul-Jensen Karen Bukumiric Zoran M Clausen Michael Roost Ludvigsen Al-Mashhadi Ahmed Pedersen Robert Schou Poulsen Christian Bjorn Brown Peter El-Galaly Tarec Christoffer Stauffer Larsen Thomas |
| Info | BLOOD CANCER JOURNAL, (2023), vol. 13 br. 1, str. - |
| Projekat | We thank our colleagues from the Departments for Clinical Biochemistry in Denmark for providing the necessary laboratory data and reference values for the variables used in this study. |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care (Editorial Material) |
| Autori | El-Galaly Tarec Christoffer ... Antic Darko A ... (broj koautora 16) |
| Info | HEMASPHERE, (2023), vol. 7 br. 3, str. - |
| Projekat | Cyclacel; Incyte; AbbVie; Bayer; BMS/Celgene; Gilead/Kite; Janssen; Roche; AZ; BMS; Janssen Pharma |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
